Flood Veronica H, Galderisi Faith C, Lowas Stefanie R, Kendrick Angela, Boshkov Lynn K
Division of Pediatric Hematology/Oncology, Oregon Health & Science University, Portland, Oregon, USA.
Pediatr Blood Cancer. 2008 May;50(5):1075-7. doi: 10.1002/pbc.21383.
Late hemorrhagic disease of the newborn (HDN) presents 0.5-6 months after birth with mucocutaneous and intracranial bleeding. We describe here two cases of late HDN in infants who received vitamin K. The first case is a previously healthy breastfed male who received one dose of oral vitamin K at birth and developed an intracranial hemorrhage 5 weeks later. He was treated with intravenous vitamin K and recombinant factor VIIa prior to emergent craniectomy. An unrelated infant presented at 5 months of age with diarrhea and easy bruising despite IM vitamin K at birth. These cases illustrate the morbidity associated with late HDN.
新生儿晚期出血性疾病(HDN)在出生后0.5 - 6个月出现,伴有皮肤黏膜和颅内出血。我们在此描述两例接受过维生素K治疗的婴儿晚期HDN病例。第一例是一名此前健康的母乳喂养男婴,出生时接受过一剂口服维生素K,5周后发生颅内出血。在紧急开颅手术前,他接受了静脉注射维生素K和重组凝血因子VIIa治疗。另一例不相关的婴儿在5个月大时出现腹泻且容易淤青,尽管出生时接受过肌肉注射维生素K。这些病例说明了与晚期HDN相关的发病率。